The reason why semaglutide causes bloating is largely due to its effects on slowing digestion and altering appetite signals in the brain
Weight loss alone can reduce apnea hypopnea events and nighttime oxygen drops. Tirzepatide (Zepbound) is now FDAapproved specifically to treat OSA in adults with obesity, backed by SURMOUNTOSA trials showing large drops in apneahypopnea index, hypoxic burden, and body weight versus placebo. Semaglutide is not OSAapproved but still improves apnea severity in some patients as weight and visceral fat come down, with emerging data suggesting symptom relief and better functional scores. For sleep apnea driven by obesity, both agents can help, but tirzepatide is the one positioned as a direct OSA drug today
Vision changes : Get any sudden vision changes checked immediately
Enhancing the transparency and accessibility of information on medication risks and benefits, enabling patients to make informed healthcare decisions
Thus, consumption of creatine monohydrate (3 g/day) over a prolonged period of time can beneficially increase the concentration of creatine in skeletal muscle to the saturation level even if the supplement is not taken every single day
Ci thin cht lng gic ng L - theanine c th gip cho mi ngi d ng hn